03:29 PM EST, 12/11/2024 (MT Newswires) -- Health care stocks declined late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) dropping around 1%.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, AnaptysBio ( ANAB ) shares sank 31% after the company said it would discontinue further investment in experimental therapy ANB032 after a phase 2b trial in moderate-to-severe atopic dermatitis or eczema didn't meet the primary and secondary endpoints.